In 2023, the American Heart Association (AHA) introduced a staging construct for cardiovascular, kidney, and metabolic (CKM) syndrome. Subsequently, a 2024 JAMA article found among a study population of 10,762 U.S. adults, almost 90% met criteria for CKM syndrome (stage 1 or higher), and 15% met criteria for advanced stages between 2011 and 2020. In a new survey of 4,000 adults, AHA found that only 12% of respondents had heard of CKM, and 68% incorrectly …
Read More